Cochrane Abstracts
Cannabinoids for Tourette's Syndrome
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Cannabinoids for Tourette's Syndrome." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435810/all/Cannabinoids_for_Tourette&apos.
Cannabinoids for Tourette's Syndrome. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435810/all/Cannabinoids_for_Tourette&apos. Accessed February 8, 2026.
Cannabinoids for Tourette's Syndrome. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435810/all/Cannabinoids_for_Tourette&apos
Cannabinoids for Tourette's Syndrome [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 February 08]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435810/all/Cannabinoids_for_Tourette&apos.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Cannabinoids for Tourette's Syndrome
ID - 435810
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435810/all/Cannabinoids_for_Tourette&apos
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
